+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Analysis of frequency of peripheral blood CD4+; CD25(high);Tregs and CD4+; CD25(low);T cells and expression of PD-1 in SLE and RA patients



Analysis of frequency of peripheral blood CD4+; CD25(high);Tregs and CD4+; CD25(low);T cells and expression of PD-1 in SLE and RA patients



Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27(1): 23-25



To explore the frequencies of peripheral blood CD4(+);CD25(high);Treg and CD4(+);CD25(low);T cells and the expression of the co-stimulatory molecule PD-1 on these two group cells surface in SLE and RA patients, and to explore their roles in cell immunity disorder of SLE and RA. Flow cytometry (FCM) was used to determine the frequencies of peripheral blood CD4(+);CD25(high);Treg and CD4(+);CD25(low);T cells, and the expression percentage of PD-1. Compared with healthy control, the frequencies of peripheral blood CD4(+);CD25(high);Treg from both SLE and RA patients groups decreased significantly(P<0.05). Compared between two disease groups, the frequency of peripheral blood CD4(+);CD25(high);Treg in SLE patients was significantly lower(P<0.05). The expression percentage of PD-1 on CD4(+);CD25(high);Treg surface in RA group was obviously lower than that in both healthy control and SLE patients groups(P<0.05), while the percentage had no significant difference between SLE patients and healthy control(P>0.05). There was no significant difference in both the frequency of CD4(+);CD25(low);T cells and the expression percentage of PD-1 on this subset cells among three groups. The weakened ability of peripheral blood CD4(+);CD25(high);Treg to suppress effector T cells resulted from their production deficiency is the common characteristic of SLE and RA patients. Decreased expression of PD-1 is the primary cause leading to the suppressive function of peripheral blood CD4(+);CD25(high);Treg weakened in RA patients. However, PD-1 does not play major role in weakening the suppression activity of CD4(+);CD25(high);Treg from SLE patients.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051522654

Download citation: RISBibTeXText

PMID: 21208558


Related references

Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patients. Archivum Immunologiae et Therapiae Experimentalis 44(2-3): 127-130, 1996

CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Foundation Symposium 252: 67-88; Discussion 88-91, 106-14, 2003

Preliminary study on the expression of CD4⁺CD25⁺Tregs and Foxp3 in peripheral blood of patients with head and neck squamous cell carcinoma. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 31(13): 1009-1012, 2018

1.62Stimulated by Il-15 regulatory T cells Cd4 + Cd25 ++ (Tregs) isolated form bone marrow of rheumatoid arthritis (Ra) patients suppress proliferation but not Tnf production by responder Cd4 + Cd25 - T cells. Annals of the Rheumatic Diseases 73(Suppl 1): A27.1-A27, 2014

Increased Numbers of CD4 + CD25 + and CD8 + CD25 + T-Cells in Peripheral Blood of Patients with Rheumatoid Arthritis with Parvovirus B19 Infection. In Vivo 31(2): 181-185, 2017

T cell receptor beta chain (TCR-Vbeta) repertoire of circulating CD4(+) CD25(-), CD4(+) CD25(low) and CD4(+) CD25(high) T cells in patients with long-term renal allograft survival. Transplant International 23(1): 54-63, 2010

Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes. Clinical and Experimental Immunology 150(3): 523-530, 2007

Comparison of the percentages of CD4 +  CD25 high  FOXP3 + , CD4 +  CD25 low  FOXP3 + , and CD4 +  FOXP3 + Tregs, in the umbilical cord blood of babies born to mothers with and without preeclampsia. American Journal of Reproductive Immunology 78(6), 2017

Decreased 4-1BB expression on CD4+CD25 high regulatory T cells in peripheral blood of patients with multiple sclerosis. Clinical and Experimental Immunology 154(1): 22-29, 2008

CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. Journal of Immunology 165(6): 3105-3110, 2000

(99) Tc-methylene diphosphonate improves rheumatoid arthritis disease activity by increasing the frequency of peripheral γδ T cells and CD4(+) CD25(+) Foxp3(+) Tregs. International Journal of Rheumatic Diseases 19(6): 586-593, 2017

Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells. Transplantation 82(7): 953-964, 2006

As 2 O 3 Up-Regulates the Proportion of CD4 + CD25 + CD127 low Tregs in Peripheral Blood of Patients with Severe Aplastic Anemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 26(3): 854-858, 2018

Low frequency of CD8+CD25+FOXP3(BRIGHT) T cells and FOXP3 mRNA expression in the peripheral blood of allergic asthma patients. Journal of Biological Regulators and Homeostatic Agents 26(2): 211-220, 2012

Conversion of peripheral CD4(+)CD25(-) T cells to CD4(+)CD25(+) regulatory T cells by IFN-gamma in patients with Guillain-Barré syndrome. Journal of Neuroimmunology 217(1-2): 80-84, 2009